Answers are grounded in this paper and cite their sources.
SYNOPSIS Pizotifen, a tricyclic antiserotonin agent and inhibitor of certain other biogenic amines, was effective in reducing the severity and frequency of migraine attacks, producing complete remission in some cases, in a double‐blind placebo controlled trial in 36 patients. Serious side effects were not reported during the trial period.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: